News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Hashad Yehia
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/27/2023 |
4
| Hashad Yehia (EVP of R&D and CMO) has filed a Form 4 on Bausch & Lomb Corp|
Txns:
| Paid exercise price by delivering 3,996 shares
@ $19.82, valued at
$79.2k
|
|
| 12/01/2022 |
4
| Hashad Yehia (Director) has filed a Form 4 on APPLIED GENETIC TECHNOLOGIES CORP|
Txns:
| Disposed/sold 14,000 options to buy
@ $2.17, valued at
$30.4k
Disposed/sold 25,000 options to buy
@ $3.42, valued at
$85.5k
|
|
| 07/27/2022 |
4
| Hashad Yehia (EVP, R&D and CMO) has filed a Form 4 on Bausch & Lomb Corp|
Txns:
| Granted 35,000 shares
@ $0 |
|
| 05/09/2022 |
4
| Hashad Yehia (EVP, R&D and CMO) has filed a Form 4 on Bausch & Lomb Corp|
Txns:
| Granted 34,722 shares
@ $0
Granted 137,362 options to buy
@ $18, valued at
$2.5M
|
|
| 12/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/18/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|
|